Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate vs standard postpartum insertion of Mirena LNG-IUS
2017-001945-29Phase 3Completed
- Sponsor
- Linköping University
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of avatrombopag (2 arms), sponsored by Linköping University. Primary endpoint: Number of abortions within one year after insertion of LNG-IUS. Started Jul 2017; status: completed.
02
Drugs
avatrombopag
Beyond the preview
Go deeper on 2017-001945-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001945-29.